Not finding it? Sign in to also search OpenAlex live.
-
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study
Xenofon Baraliakos, Atul A. Deodhar, Maxime Dougados, Lianne S. Gensler, Anna Moltó, Sofía Ramiro, +9 more
31citations -
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study2023 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Désirée M F M van der Heijde, Joachim Sieper, Robert Davies Inman, Hideto Kameda, Yihan Li, +5 more
26citations -
ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
Evert S.M. van Aken, Bharti Devnani, Arsela Prelaj, Luís Castelo-Branco, Corrie A.M. Marijnen, Diogo Alexandre Martins-Branco, +21 more
23citations -
The Role of Prison Climate and Work Climate in Understanding Subjective Safety Among Correctional Staff2022 Criminal Justice and Behavior article Social Sciences Criminal Justice and Corrections Analysis Open access
Hanneke M. H. Palmen, Miranda Sentse, Esther F. J. C. van Ginneken, Anouk Q. Bosma
22citations -
Clinical predictors and neural correlates for compromised swallowing safety in Huntington disease2021 European Journal of Neurology article Health Professions Dysphagia Assessment and Management Open access
Beate Schumann‐Werner, Imis Dogan, Shahram Mirzazade, Bettina Mall, Rena Overbeck, Philipp Honrath, +3 more
18citations -
Rebel with a cause: The effects of leadership encouragement and psychological safety on professionals' prosocial r ulebreaking behavior2023 Public Administration article Business, Management and Accounting Job Satisfaction and Organizational Behavior Open access
Bernard Bernards, Eduard J.E.T. Schmidt, Sandra M. Groeneveld
18citations -
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
Fernando Ferrero, Chien‐Yu Lin, Johannes G. Liese, Kléber Giovanni Luz, T. Stoeva, Ágnes Németh, +14 more
15citations -
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study2024 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +9 more
14citations -
First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management2021 British Journal of Clinical Pharmacology article Medicine Pain Mechanisms and Treatments Open access
Laurence M. Moss, Cécile L. Berends, Emilie M.J. van Brummelen, Ingrid M. C. Kamerling, Erica Surya Klaassen, Kirsten Riber Bergmann, +4 more
11citations -
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors2025 Radiotherapy and Oncology article Physics and Astronomy Advanced Radiotherapy Techniques Open access
Evert S.M. van Aken, Ajeet Kumar Gandhi, Sean Michael O'Cathail, Gerben R. Borst, Jorge Barriuso, Emmanouil Fokas, +26 more
8citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations -
Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol2024 Clinical Cancer Research article Mathematics Statistical Methods in Clinical Trials Open access
Jade M. van Berge Henegouwen, Laurien Joanna Zeverijn, Birgit S. Geurts, Louisa Rose Hoes, Hanneke van der Wijngaart, Vincent van der Noort, +7 more
2citations -
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study
Emily S.L. Martens, Bram Akerboom, Christine Baumgartner, Brouwer Re, Chiara Cavallaro, Michiel Coppens, +30 more
0citations -
Lung volume reduction with one-way valves in patients with a very low FEV1: Assessment of efficacy and safety up to 6 months with results from the German Lung emphysema registry (LE-R)
Thomas Sgarbossa, Franz Stanzel, Angélique Holland, Christian Grah, Wolfgang Gesierich, Joachim Hans Ficker, +8 more
0citations -
A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).
Andrei H. Iagaru, GIUSEPPE T. CARDACI, Aaron Richard Hansen, Jeffrey Y.C. Wong, Carlos Artigas, Karolien E. Goffin, +7 more
0citations -
Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial2023 Journal of the American Heart Association article Medicine Lipoproteins and Cardiovascular Health Open access
Shaun G. Goodman, Philippe Gabríel Steg, Yann Poulouin, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, +8 more
43citations -
Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database2022 Alimentary Pharmacology & Therapeutics article Medicine Pregnancy and Medication Impact Open access
Uma Mahadevan, Saule Naureckas, Ilia Tikhonov, Yiting Wang, Connie B. Lin, Anja B. Geldhof, +1 more
31citations -
Safety, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of AZD2936, a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-experienced advanced/metastatic non-small-cell lung cancer (NSCLC): First report of ARTEMIDE-01.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Kristoffer Staal Rohrberg, Mariana Brandão, Eduardo Castañón Álvarez, Enriqueta Felip, Eelke Hiddo Gort, T. Jeroen N. Hiltermann, +14 more
22citations -
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study2023 The Journal of Infectious Diseases article Medicine Respiratory viral infections research Open access
Christy A. Comeaux, Stephan Bart, Arangassery Rosemary Bastian, V. G. Klyashtorny, Els De Paepe, Edmund V Ekoka Omoruyi, +5 more
21citations